Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report

BACKGROUND: Hypoproliferative anemia is a frequently encountered adverse event in cancer patients receiving immune checkpoint inhibitors (ICI). Secondary pure red cell aplasia (PRCA) is a rare but recognized immune related adverse event. With the burgeoning use of ICIs, the association of secondary...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Vaibhav, Montgomery, Nathan D., van Deventer, Hendrik W., Whang, Young E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225080/
https://www.ncbi.nlm.nih.gov/pubmed/37245043
http://dx.doi.org/10.1186/s13256-023-03948-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225080/
https://www.ncbi.nlm.nih.gov/pubmed/37245043
http://dx.doi.org/10.1186/s13256-023-03948-4

Ejemplares similares